Form 4: Castle Biosciences Director Olson Reports Stock Unit Vesting
SEC Form 4 Filing
Director Tiffany Olson reports the vesting of 8,636 Restricted Stock Units (RSUs) into common stock of Castle Biosciences.
Summary
- On May 25, 2024, Tiffany Olson, a director of Castle Biosciences, had 8,636 Restricted Stock Units (RSUs) vest.
- Each RSU represents the right to receive one share of Castle Biosciences' common stock.
- The RSUs vested in full on the one-year anniversary of the grant date, May 25, 2024.
- Following the transaction, Olson directly owns 16,403 shares of Castle Biosciences common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock ownership. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and equity ownership, common in publicly traded companies. It provides transparency regarding the holdings of company insiders.
Stakeholder Impact
- The vesting of RSUs may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/25/2024 | Date of transaction: Vesting of Restricted Stock Units (RSUs). |
| 05/25/2024 | RSUs vested in full on the one-year anniversary of the date of grant. |
| 05/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.